Chris Boshoff

Chris Boshoff

President at SEAGEN INC.

Net worth: 4 M $ as of 2026-05-30

Health Technology
Commercial Services
Consumer Services

Profile

Chris Boshoff currently works at Pfizer Inc., as President-R&D & Chief Scientific Officer from 2025, Seagen, Inc., as President from 2023, and Pfizer (La Jolla), as Vice President-Translational Oncology.
Dr. Boshoff also formerly worked at Advanced Oncotherapy Plc, as Non-Executive Director in 2013 and UCL Cancer Institute Research Trust, as Founding Director.
Dr. Boshoff received his doctorate degree from Institute of Cancer Research Royal Marsden Hospital.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-03-02 162,088 ( 0% ) 4 M $ 2026-05-30

Chris Boshoff active positions

CompaniesPositionStart
PFIZER INC. Chief Tech/Sci/R&D Officer 2024-12-31
SEAGEN INC. President 2023-12-13
Corporate Officer/Principal -

Former positions of Chris Boshoff

CompaniesPositionEnd
ADVANCED ONCOTHERAPY PLC Director/Board Member 2013-10-24
UCL Cancer Institute Research Trust
Director/Board Member -
See the detail of Chris Boshoff's experience

Training of Chris Boshoff

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

25

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Health Technology

Health Technology

Commercial Services

UCL Cancer Institute Research Trust

Consumer Services